Jasper Ridge Partners’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,706
| Closed | -$55.7K | – | 149 |
|
|
2025
Q1 | $55.7K | Hold |
5,706
| – | – | ﹤0.01% | 141 |
|
|
2024
Q4 | $72.1K | Hold |
5,706
| – | – | ﹤0.01% | 139 |
|
|
2024
Q3 | $91.8K | Hold |
5,706
| – | – | ﹤0.01% | 136 |
|
|
2024
Q2 | $139K | Hold |
5,706
| – | – | ﹤0.01% | 135 |
|
|
2024
Q1 | $410K | Hold |
5,706
| – | – | 0.01% | 109 |
|
|
2023
Q4 | $1.13M | Hold |
5,706
| – | – | 0.05% | 83 |
|
|
2023
Q3 | $759K | Hold |
5,706
| – | – | 0.04% | 87 |
|
|
2023
Q2 | $854K | Hold |
5,706
| – | – | 0.04% | 85 |
|
|
2023
Q1 | $838K | Hold |
5,706
| – | – | 0.04% | 90 |
|
|
2022
Q4 | $904K | Hold |
5,706
| – | – | 0.05% | 82 |
|
|
2022
Q3 | $1.1M | Hold |
5,706
| – | – | 0.07% | 79 |
|
|
2022
Q2 | $833K | Hold |
5,706
| – | – | 0.05% | 88 |
|
|
2022
Q1 | $1M | Hold |
5,706
| – | – | 0.05% | 86 |
|
|
2021
Q4 | $1.68M | Hold |
5,706
| – | – | 0.06% | 82 |
|
|
2021
Q3 | $1.42M | Buy |
+5,706
| New | +$1.42M | 0.06% | 93 |
|